Urolithin A Market is Segmented by Type (Purity: >98%, Purity: >99%), by Application (Food Additives, Cosmetics, Drugs and ...
Expected to enhance global innovator flexibility with biologics drug substance facility in Baltimore BANGALORE, India, March ...
March 11 (Reuters) - A federal judge ruled in favor of Merck (MRK.N), opens new tab in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent cervical and other cancers ...
Merck is bracing for the years of sales growth from oncology superstar Keytruda to take a sharp turn in 2028—and for more reasons than one. Along with a key U.S. patent expiring at the end of ...
Both Merck & Co. and Halozyme are holding their ground in a freshly unveiled patent dispute surrounding the New Jersey pharma’s under-the-skin version of its blockbuster cancer drug Keytruda.
Trial adjourned, new jury due to reconvene in September Kennedy helped organize litigation against Merck before HHS role Merck denies claims, cites scientific evidence supporting Gardasil safety ...
Bengaluru: Prayoga Institute of Education Research on Friday announced its partnership with Merck, a science and technology company, to expand its pioneering initiative, Kriya, to 45 government ...
Biotech Halozyme Therapeutics believes the new version of Merck's blockbuster cancer drug Keytruda infringes on its patents, the Wall Street Journal reported on Wednesday (March 5, 2025), citing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results